(Q44852640)

English

Pharmacokinetics of a new Autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers.

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Pharmacokinetics of a new Autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

pharmacokinetics

1 reference

based on heuristic

inferred from title

José Antonio Cordero

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

R M Antonijoan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M J Barbanoj

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

C Peraire

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

R Obach

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

J Vallès

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

R Chérif-Cheikh

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M-L Torres

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

F Bismuth

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M Montes

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

56

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

471-476

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Epidemiology of acromegaly in the Newcastle region.

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Efficacy and tolerability of the long-acting somatostatin analog lanreotide in acromegaly. A 12-month multicenter study of 58 acromegalic patients. French Multicenter Study Group on Lanreotide in Acromegaly.

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly.

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Stimulatory and Inhibitory Effects of Purified Hypothalamic Extracts on Growth Hormone Release from Rat Pituitaryin Vitro1

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Carcinoid tumors.

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Pathophysiology of Acromegaly*

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance.

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms.

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Octreotide treatment of acromegaly. A randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Pharmacokinetics and efficacy of the long-acting somatostatin analogue somatuline in acromegaly

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Treatment of acromegaly.

1 reference

https://api.crossref.org/works/10.1211%2F0022357023123

21 January 2018

Identifiers

10.1211/0022357023123

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15099442%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44852640&oldid=2143467134"